Replies to post #274424 on NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

All of what Umibe says is reasonable.

But what’s telling is Duffy’s upfront compensation didn’t include much in the way of options, from what we can tell, and I doubt he was making much more at NWBO than Merck. If someone is leaving to work for a startup because of the financial upside, the one thing you want is options and shares.

Anything is possible, but it seemed odd from almost the very beginning.